(Q44461726)

3 December 2017

title

Plasma homocysteine levels in systemic lupus erythematosus (English)

1 reference

3 December 2017

author

Guillermo Ruiz-Irastorza

2

object named as

Guillermo Ruiz-Irastorza

1 reference

3 December 2017

author name string

Agustín Martínez-Berriotxoa

1

1 reference

3 December 2017

María Victoria Egurbide Arberas

3

1 reference

3 December 2017

Miguel Rueda Gutiérrez

4

1 reference

3 December 2017

Ciriaco Aguirre Errasti

5

1 reference

3 December 2017

language of work or name

Spanish

0 references

publication date

1 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

120

1 reference

3 December 2017

issue

18

1 reference

3 December 2017

page(s)

681-685

1 reference

Systemic lupus erythematosus

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Premature atherosclerosis in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Risk factors for coronary artery disease in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Antiphospholipid antibodies and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Population reference ranges and determinants of plasma homocysteine levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Homocysteine and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Plasma homocysteine in the acute and convalescent phases after stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Serial measures of plasma homocyst(e)ine after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Homocysteine and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Hyperhomocysteinemia and Atherosclerotic Vascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Clinical significance of homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Homocysteine and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Homocysteine and cardiovascular disease: cause or effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

The controversy over homocysteine and cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Plasma homocysteine levels and mortality in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2803%2973812-3

10.1016/S0025-7753(03)73812-3

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference